Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: real-life experience

BACKGROUND: Hereditary angioedema (HAE) due to C1 esterase inhibitor (C1-INH) deficiency is characterized by recurrent swelling attacks that can be life-threatening if left untreated. Prompt treatment is vital during acute attacks; plasma-derived C1-INH (Berinert(®)) is one treatment currently licen...

Descripción completa

Detalles Bibliográficos
Autor principal: Dempster, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201499/
https://www.ncbi.nlm.nih.gov/pubmed/30386384
http://dx.doi.org/10.1186/s13223-018-0267-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201499/
https://www.ncbi.nlm.nih.gov/pubmed/30386384
http://dx.doi.org/10.1186/s13223-018-0267-4

Ejemplares similares